All articles tagged: Unspecified symptoms and signs involving cognitive functions and awareness (R41.9)
![]()
HealthDay
02 July at 04.04 PM
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary CareA self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases detection of new cognitive conditions/concerns in older adults, according to a study published online June 12 in Frontiers in Medicine.Douglas W. Scharre, M.D., from The Ohio State Univ |
![]()
HealthDay
28 June at 09.42 PM
Lower Cognitive Function in Adolescence Linked to Stroke RiskLower cognitive function in adolescence is associated with increased risk of early-onset stroke, according to a study published online June 27 in the Journal of Epidemiology & Community Health.Aya Bardugo, M.D., from the Hebrew University in Jerusalem, and colleagues examined the association between adolescent cognitive function and |
![]()
HealthDay
24 June at 03.03 PM
Vigorous Physical Activity May Preserve Cognitive Function in High-Risk HTNFor high-risk patients with hypertension, vigorous physical activity (VPA) may preserve cognitive function, according to a study published online June 6 in Alzheimer's & Dementia.Richard Kazibwe, M.D., from the Wake Forest University School of Medicine in Winston-Salem, North Carolina, and colleagues categorized the baseline self-re |
![]()
HealthDay
13 June at 04.08 PM
Lifestyle Intervention Can Improve Cognition, Function in Early Alzheimer DiseaseFor patients with mild cognitive impairment (MCI) or early dementia due to Alzheimer disease (AD), comprehensive lifestyle changes may improve cognition and function, according to a study published online June 7 in Alzheimer's Research & Therapy.Dean Ornish, M.D., from Preventive Medicine Research Institute in Sausalito, Californi |
![]()
Evalytics
06 May at 07.23 PM
The Impact of a Western Diet High in Fats and Sugars on Memory and Brain Development in Young IndividualsThe article discusses the worrying trend of young people consuming high-fat, high-sugar Western diets. It highlights studies showing the negative impact on cognitive function and brain health. Overall, it emphasizes the risks and neurological implications of prolonged consumption of this diet among the youth. |
![]()
HealthDay
05 December at 09.59 PM
One in Seven Adults Report Experiencing Long COVIDOne in seven U.S. adults report having had long COVID at some point, according to a study published online Nov. 2 in PLOS ONE.David G. Blanchflower, Ph.D., from Dartmouth University in Hanover, New Hampshire, and Alex Bryson, Ph.D., from University College London, used data from the U.S. Census Bureau Household Pulse Survey (June t |
![]()
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
![]()
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
![]()
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
![]()
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |
Medpage Today
13 June at 06.56 PM
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... |
Medpage Today
08 June at 04.00 PM
Here Are the Top Supreme Court Health Cases to WatchBy early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... |